Bio-Seal Lung Plug System Prevents Post-Biopsy Pneumothorax

December 21st, 2012 Editors Radiology, Thoracic Surgery

Lung biopsies naturally puncture the organ, sometime leading to a pneumothorax (collapsed lung) – a potentially life-threatening complication.

The FDA has just cleared the Bio-Seal Lung Biopsy Tract Plug System from Angiotech, which allows physicians to apply a special hydrogel plug to the needle entrance site and block air from exiting through the hole. The hydrogel expands after coming in contact with body liquids after imlantation. After some time it is slowly resorbed by the body and so does not have to be removed in a follow up procedure.

Features from the product page:

Bio-Seal™ is a single use disposable system intended for the prevention of pneumothorax following percutaneous lung biopsy.

The patented hydrogel plug resorbs into the patient’s body after healing of the puncture site has occurred.

Each Bio-Seal™ system features two sets of plugs and co-axial adaptors to accommodate multiple lung biopsy sites.

Angiotech™ offers a broad range of 19G introducers designed for compatibility with the Bio-Seal™plug adaptor. These introducers maybe used in conjunction with any 20G or 22G biopsy device.

Link to animation showing how the Bio-Seal plug is inserted…

FDA news release: FDA permits marketing of device to seal lung punctures

Product page: Bio-Seal

Upcoming conferences

october

18octallday19alldayWorld Congress on Polycystic Ovarian Syndrome and Fertility, 2018Abu Dhabi, UAE

18octallday19alldayManaging Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an InspectionMinneapolis, MN, USA

Event Details

Post-Market activities, Complaint Handling, MDRs, and Recalls are expensive, time consuming, and often lead to more serious financial consequences. Over 80% of FDA Inspection target observations for lack of compliance in these areas.

By attending this seminar, you will discover:

How to overcome one of the biggest obstacles device manufacturers face
How the FDA expects you to develop and implement proper handling of complaints reportable or non-reportable, product complaint handling and documentation
How and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall.
How to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.

**New course materials have been added, updated content will include:

Creating Standard Operating Systems (SOPs) for Post-Market Quality Systems and
What to expect from the changes in ORA with Inspection Structure Realignment

This Seminar will have you stop spinning your wheels with nonessential activities, and leave you with a comprehensive learning package that only Rita Hoffman, a former FDA CDRH Recall Branch Chief with experience across the device, drug and veterinary industries can provide.

Spend one and a half days in an interactive course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief with over 36 years with FDA and leading Industry Expert, who will provide the participants with tools to minimize risk of regulatory enforcement actions.

Time

october 18 (Thursday) - 19 (Friday)

Organizer

Compliance Online 80068SEM

Learn More

Calendar GoogleCal

18octallday19allday18th Global Ophthalmology, Optometry and Glaucoma Conference, 2018Helsinki, Finland

18octallday19alldayBiology and Pathology of Infectious Disease Conference, 2018Helsinki, Finland

18octallday19allday14th Global Biomarkers Summit, 2018Amsterdam, Netherlands

22octallday23alldayInternational Conference on Breast Cancer, 2013Vancouver, British Columbia, Canada